This inventor holds 1 USPTO granted patent. Top assignee: Genentech, Inc.. Active years: 1995.
Company Filing History:
Years Active: 1995
Title: David A Vetterlein: Innovator in Protein Purification
Introduction
David A Vetterlein is a notable inventor based in Union City, CA (US). He has made significant contributions to the field of biotechnology, particularly in the purification of recombinant proteins. His innovative methods have the potential to enhance the efficiency of protein purification processes.
Latest Patents
David A Vetterlein holds a patent for a method of purifying recombinant proteins from corresponding host cells. This patent, which is particularly relevant for purifying human tissue plasminogen activator (t-PA), involves contacting a fluid containing the recombinant protein with antibodies that specifically bind to the corresponding endogenous protein. The method also includes the use of monoclonal antibodies directed against Chinese hamster t-PA, along with an assay for its detection. He has 1 patent to his name.
Career Highlights
Vetterlein is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Genentech has allowed him to apply his expertise in protein purification to real-world applications, contributing to advancements in medical treatments.
Collaborations
Throughout his career, David has collaborated with several esteemed colleagues, including Billie J Marks and John R Ogez. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.
Conclusion
David A Vetterlein is a prominent figure in the field of biotechnology, with a focus on the purification of recombinant proteins. His contributions, particularly through his patent, demonstrate his commitment to advancing scientific knowledge and improving biotechnological processes.